ANI Pharma (ANIP) Misses Q2 EPS by 21c, Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharma (ANIP) Misses Q2 EPS by 21c, Updates Guidance

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

August 7, 2018 8:30 AM EDT

BAUDETTE, Minn., Aug. 7, 2018 /PRNewswire/ -- 

For the second quarter 2018:

Net revenues of $47.3 million, an increase of 6% as compared to the same period in 2017  GAAP net income of $2.8 million and diluted GAAP earnings per share of $0.23 Adjusted non-GAAP EBITDA of $19.0 million Adjusted non-GAAP diluted earnings per share of $1.13

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported its financial results for the three and six months ended June 30, 2018 and updated its 2018 financial guidance. The Company... More